These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 577169)

  • 1. [First-past Effect (author's transl)].
    Leopold G
    Arzneimittelforschung; 1977 Feb; 27(2A):241-9. PubMed ID: 577169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic model of presystemic metabolism.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-pass effect of coumarin in man.
    Ritschel WA; Brady ME; Tan HS
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):99-103. PubMed ID: 429086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems in dose finding from the view of the clinical pharmacologist (author's transl)].
    Weber E
    Arzneimittelforschung; 1977 Feb; 27(2A):264-72. PubMed ID: 577173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and miotic effects of oral alfentanil: a potential noninvasive probe for first-pass cytochrome P4503A activity.
    Kharasch ED; Hoffer C; Walker A; Sheffels P
    Clin Pharmacol Ther; 2003 Mar; 73(3):199-208. PubMed ID: 12621385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new model for demonstrating the hepatic first-pass effect (author's transl)].
    Bickel M; Brettel HF; Jung S; Schleyerbach R
    Arzneimittelforschung; 1977; 27(10):1879-81. PubMed ID: 579096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences in drug pharmacokinetics and effects upon oral versus parenteral administration. Review with special interest in first-pass effect on the liver].
    Morland J
    Tidsskr Nor Laegeforen; 1976 Mar; 96(9-10):554-8. PubMed ID: 1258025
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chirality on pharmacokinetics and pharmacodynamics.
    Crom WR
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S9-14. PubMed ID: 1530005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass metabolism.
    Brodie MJ
    Practitioner; 1983 Oct; 227(1384):1619-27. PubMed ID: 6634632
    [No Abstract]   [Full Text] [Related]  

  • 17. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?
    Ammon E; Schäfer C; Hofmann U; Klotz U
    Clin Pharmacol Ther; 1996 May; 59(5):503-13. PubMed ID: 8646821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intercellular distribution of drug-metabolizing enzymes on the kinetics of stable metabolite formation and elimination by liver: first-pass effects.
    Pang KS
    Drug Metab Rev; 1983; 14(1):61-76. PubMed ID: 6839942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.